Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Jones

Showing results (91-100 of 165) with videos related to

Pageof 17
Sort By:
Cancer Research|November 20, 2002
Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidineCarvell T Nguyen, Daniel J Weisenberger, Mihaela Velicescu, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapyVictor E Marquez, James A Kelley, Riad Agbaria, et al.
Nucleic Acids Research|February 15, 2013
Functional DNA demethylation is accompanied by chromatin accessibilityKurinji Pandiyan, Jueng Soo You, Xiaojing Yang, et al.
Plos One|October 8, 2010
Equitoxic doses of 5-azacytidine and 5-aza-2'deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptomeXiangning Qiu, Christoffer Hother, Ulrik M Ralfkiær, et al.
Molecular and Cellular Biology|January 5, 2002
Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elementsGangning Liang, Matilda F Chan, Yoshitaka Tomigahara, et al.
BMC Cancer|June 6, 2013
Diagnostic markers of urothelial cancer based on DNA methylation analysisYoshitomo Chihara, Yae Kanai, Hiroyuki Fujimoto, et al.
Communications Biology|June 2, 2022
Chromosome-specific retention of cancer-associated DNA hypermethylation following pharmacological inhibition of DNMT1Ashley K Wiseman, Rochelle L Tiedemann, Huihui Fan, et al.
Cancer Research|March 5, 2009
The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2Jeffrey M Friedman, Gangning Liang, Chun-Chi Liu, et al.
Plos Genetics|May 3, 2013
SNF5 is an essential executor of epigenetic regulation during differentiationJueng Soo You, Daniel D De Carvalho, Chao Dai, et al.
Molecular Cancer Therapeutics|October 18, 2005
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidineJody C Chuang, Christine B Yoo, Jennifer M Kwan, et al.
Pageof 17

Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
Cancer Research|November 20, 2002
Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidineCarvell T Nguyen, Daniel J Weisenberger, Mihaela Velicescu, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapyVictor E Marquez, James A Kelley, Riad Agbaria, et al.
Nucleic Acids Research|February 15, 2013
Functional DNA demethylation is accompanied by chromatin accessibilityKurinji Pandiyan, Jueng Soo You, Xiaojing Yang, et al.
Plos One|October 8, 2010
Equitoxic doses of 5-azacytidine and 5-aza-2'deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptomeXiangning Qiu, Christoffer Hother, Ulrik M Ralfkiær, et al.
Molecular and Cellular Biology|January 5, 2002
Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elementsGangning Liang, Matilda F Chan, Yoshitaka Tomigahara, et al.
BMC Cancer|June 6, 2013
Diagnostic markers of urothelial cancer based on DNA methylation analysisYoshitomo Chihara, Yae Kanai, Hiroyuki Fujimoto, et al.
Communications Biology|June 2, 2022
Chromosome-specific retention of cancer-associated DNA hypermethylation following pharmacological inhibition of DNMT1Ashley K Wiseman, Rochelle L Tiedemann, Huihui Fan, et al.
Cancer Research|March 5, 2009
The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2Jeffrey M Friedman, Gangning Liang, Chun-Chi Liu, et al.
Plos Genetics|May 3, 2013
SNF5 is an essential executor of epigenetic regulation during differentiationJueng Soo You, Daniel D De Carvalho, Chao Dai, et al.
Molecular Cancer Therapeutics|October 18, 2005
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidineJody C Chuang, Christine B Yoo, Jennifer M Kwan, et al.
Pageof 17